From Afterthought to Front of Shelf: A Pre-Roll Deep Dive

Introduction

The Pre-Roll category has spent years being underestimated. Retailers treated it as a convenience item. Brands treated it as a commodity. Consumers, apparently, did not get the memo.

In Q1 2026, Pre-Roll is the fastest-growing major cannabis category in the US and the top-selling category in Canada. It has climbed from a format defined by low price points and low expectations into one defined by infused innovation, multipack loyalty, and a consumer base that cuts across every demographic cohort. The story of the Pre-Roll category  in 2026 is not a story about one thing going right. It is a story about a format that found its moment and is now accelerating.

This report examines the data behind that acceleration across the US and Canada in Q1 2026, covering category share trends, market-by-market performance, product format shifts, brand dynamics, pricing, and the consumer demographics that will shape where the category goes next.

Methodology

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked to Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider.

Unless otherwise noted, sales data is from ON, AB, SK, BC, markets in Canada and WA, OR, CA, AZ, CO, MI, FL, MA, NV, MD, IL, NY, OH, NJ, CT markets in the US. The following analysis reports on sales occurring in Q1 of 2026 unless otherwise indicated.

Key Takeaways

• The Pre-Roll category reached 15.9% of total US cannabis sales in Q1 2026, up 9.8% YoY, making it the only major inhalable category gaining share consistently across all tracked markets.
• In Canada, Pre-Roll is now the single largest cannabis category at 32.4% of sales, having overtaken Flower in mid-2025 and held that position through Q1 2026.
• Infused / Connoisseur formats account for 48.5% of US Pre-Roll sales, cementing their position as the category's dominant segment and primary growth engine. Canada tells the opposite story, with traditional single-strain formats regaining ground.
• Multipacks now represent 54.2% of US Pre-Roll sales, growing at 2.5x the rate of singles YoY. In Canada, multipacks are essentially the default format at 86.3% share, with the 5-pack surging 50.1% YoY.
• Pre-Roll products over-indexes with women in both markets by roughly 4 pp versus total cannabis, one of the clearest and most consistent demographic edges in the Pre-Roll category.
• Gen Z under-indexes in Canada by 5 pp, a notable gap in the market where Pre-Roll already leads, raising longer-term questions about category durability as generational buying power shifts.
• Price compression is real but proportionate in the US, with Pre-Roll down 8% YoY in line with other inhalables. Canada's steeper decline of 5.4% YoY, faster than Flower and Vapor Pens, signals that mature-market margin pressure is setting in.
• Connecticut, New York, and New Jersey are experiencing the deepest YoY price cuts among US states, consistent with newer markets correcting toward competitive parity rather than structural weakness.

Sales Performance

Assortment

The two sides of the North American Pre-Roll story couldn't look more different and that contrast is the most important thing this chart shows.

In the US, Pre-Roll is still climbing toward relevance. At 15.9% of Q1 2026 sales, it trails both Flower (39.2%) and Vapor Pens (25.3%) by a wide margin, but it's the only major category posting consistent year-over-year share gains. The 0.5 pp QoQ dip is seasonal noise; the +9.8% YoY growth rate tells the real story. Pre-Roll is taking share from a market it has structurally underpenetrated for years, and the data suggests that process isn't finished.

In Canada, the transformation is already complete. Pre-Roll has claimed the top spot at 32.4% of Q1 2026 sales, narrowly edging out Flower (31.7%) to become the country's best-selling cannabis category. The Q1 dip of 1.7 pp QoQ is consistent with the seasonal softening seen across all categories, but the +5.2% YoY gain confirms this is a structural leadership position, not a temporary spike. What Canada's market looks like today is a credible preview of where the US market is heading.

Market Analysis

The state-level picture reveals two things happening simultaneously in the US: a uniform short-term dip, and a broad long-term advance. Almost every tracked state slipped quarter-over-quarter in Q1 2026 an indication of a seasonal pattern, not a signal of structural weakness. Underneath that noise, the YoY trend is unambiguous: Pre-Roll share rose in every single state, led by Missouri at an extraordinary +22% relative increase in market share. Markets that were skeptical of the format two years ago are now among its fastest adopters.

The gap between leaders and laggards still tells the most important story for operators. Massachusetts commands 20.4% Pre-Roll share, more than one in five cannabis dollars, while Maryland sits at just 11.6%. That 9 pp spread isn't random; it maps closely to market maturity, retail sophistication, and infused product availability. The states at the bottom of this chart today look a lot like Massachusetts did three years ago.

In Canada, the story rhymes but runs ahead by several years. BC leads all tracked markets at 36.4%, a level that would be the envy of any US state, with even the lowest-share province, Saskatchewan, sits at 25.2%, well above most US competitors. The broad Q1 QoQ pullback (Ontario was hardest hit at -6.9 pp) reflects the same seasonal dynamics seen in the US, and the +8.5 pp YoY gain in Saskatchewan confirms that even Canada's less-developed Pre-Roll markets are still catching up to the leaders. Despite an already massive Pre-Roll market that sit atop the Canadian market, Pre-Rolls have still posted a YoY increase of ~5% in market share showing still some potential room for growth.

Category Performance Over Time

Zoom out 15 months and the US Pre-Roll trajectory becomes impossible to ignore. While Flower flatlined around 40% and Vapor Pens barely budged from their 25% band, Pre-Roll was the only major category in continuous, uninterrupted motion climbing from 14.1% in January 2025 to 16.4% by March 2026, a gain of 2.3 pp in just over a year. In a market where category shares typically move in fractions, that kind of sustained directional move signals a genuine consumer preference shift, not a blip.

The Canadian chart tells a more dramatic version of the same story. Pre-Roll didn't just grow in Canada, it crossed a historic threshold, overtaking Flower as the country's top-selling cannabis category in mid-2025 and holding that position ever since. Share surged from 30.2% in January 2025 to a summer peak near 36% before settling at 33% by March 2026, comfortably ahead of Flower at 31.2%.

Taken together, these two charts frame the central question for the Pre-Roll category in 2026: not whether it will grow, but how quickly the US will follow Canada's lead. For Canada, already atop the industry, how far can it climb before it finds its ceiling.

Brand & Product Performance

Top Brands

‍

Top Products

‍

Metadata Traits

Segment

The US and Canada are telling two very different stories about where consumer taste is heading, and the divergence matters.

In the US, the infused wave is still building. Connoisseur / Infused now commands 48.5% of Pre-Roll category sales, up on both a QoQ and YoY basis, while Hybrid - Single Strain has slipped to 36.1% and is losing ground on both timeframes. The consolidation around infused products is not a recent blip; it reflects a sustained shift in what US consumers expect from the format. Even at the margins, the signal is consistent: CBD - Single Strain is the fastest-growing segment at +21.6% YoY, but from a negligible 0.2% base. Mixed Strain and Cannagars / Blunts are both contracting. The US shelf is simplifying around a clear winner.

Canada tells the opposite story. Hybrid - Single Strain holds the top position at 37.2% and while it slipped modestly QoQ, it is slightly higher YoY. Connoisseur / Infused, at 34.4%, is actively losing ground, down 8.2% YoY. The momentum in Canada has rotated back to traditional formats: Indica - Single Strain is up 21.7% YoY, Sativa - Single Strain jumped 10.3% QoQ, and the niche segments like Mixed Strain and Cannagars / Blunts are shrinking. Canadian consumers appear to be pulling back from the infused premiumization trend that is accelerating south of the border.

For brands operating in both markets, these are not minor regional differences. They point to fundamentally different product strategies: infused-first in the US, single-strain quality in Canada. (All change rates refer to growth in share, not percentage-point shifts.)

Package Size

The 1g format has held the top spot in the US for years, and at 40.2% of Q1 2026 sales, it is not going anywhere. But the growth story belongs to other sizes. The 1g format is actually down 3% YoY in share terms, inching upward QoQ only because the sizes immediately below it are softening faster. The real momentum sits at the extremes: 5g packs grew 26.7% YoY from a small base, and 1.2g expanded 9.6% YoY. Mid-tier sizes like 1.5g and 2g are both contracting, squeezed between a resilient 1g anchor and a consumer appetite for larger value formats.

In Canada, a more dramatic reordering is underway. The 1.5g format, long the defining package size of the Canadian Pre-Roll shelf, held 20% of sales in Q1 2026 but fell 19.8% YoY. Consumers are voting with larger purchases: 5g is up 50.1% YoY, 2g is up 19.6%, and 2.5g is trending upward as well. The shift reflects something broader than a preference for bulk convenience. It tracks closely with the segment data above: as single-strain formats regain ground in Canada, consumers appear willing to commit to larger quantities of trusted products rather than paying a premium for infused singles.

Multi-Packs

Multipacks have quietly become the default format for Pre-Roll consumers in both markets, but the two countries are at very different points in that story.

In Canada, the shift is essentially complete. Multipacks accounted for 86.3% of all Pre-Roll sales in Q1 2026, up from 86.1% a year prior. With only fractional share left to gain, Canada is no longer a multipack adoption story. It is a multipack maturation story, where competition now plays out within the format rather than for it.

The US is still in motion. Multipacks reached 54.2% of Pre-Roll sales in Q1 2026, up from 52.7% a year ago, growing at +10.7% YoY compared to just +4.2% for singles. That gap is meaningful: multipacks are not just riding category growth, they are actively pulling share away from singles. At the current pace, multipacks could cross 57% by end of 2026.

Format preferences diverge sharply between the two markets. In the US, the 5-pack is dominant, commanding 56% of all multipack revenue at an average price of $23.65. Consumers have largely coalesced around one format. Canada is more fragmented: the 10-pack (28% of multipack sales), 3-pack (28%), and 5-pack (24%) all compete closely, with no single format in control. The 20-pack, essentially absent in the US, holds a 5% share in Canada, pointing to a consumer base more comfortable buying in bulk.

Four US states sit well below the national average and represent the clearest near-term opportunity for multipack expansion: Massachusetts (34.2%), Michigan (36.0%), Nevada (38.0%), and Colorado (38.9%). Each is 15 to 20 points below the US average, yet all four gained share year over year, with Colorado and Michigan each moving roughly 4 points. The trajectory is right; the gap just remains large.

Attachment Rate

Pre-Roll does something that most cannabis categories cannot claim: it makes other baskets bigger. Across both the US and Canada, Pre-Roll is the single most frequently attached category in cannabis retail, showing up as an add-on more often than any other product type regardless of what a consumer originally came in to buy.

The data is consistent across categories. In the US, Pre-Roll attaches to Beverage baskets at a 22% rate, Edible baskets at 18.5%, and Concentrates baskets at 15.5%. In Canada, the pattern holds with slightly lower absolute rates: 20.8% for Beverage, 15.7% for Edible, 13.1% for Concentrates. Across four of the five major categories tracked, Pre-Roll ranks as the number one add-on in Canada and a top-two add-on in the US. No other category comes close to that consistency.

The flip side of the attachment story is what Pre-Roll buyers add to their own baskets. In the US, roughly 17% of Pre-Roll purchasers also pick up Flower, and 14% add Vapor Pens. Edibles attach at 10%. These consumers are building inhalable-focused baskets, often pairing Pre-Roll with at least one other format in the same trip. In Canada, co-purchase rates are lower across the board: Flower attaches at 5.8%, Vapor Pens at 4.9%, Edibles at 4.2%. Canadian Pre-Roll buyers are more singularly focused, which aligns with the broader picture of a mature category that has become a destination purchase rather than a discovery one.

The practical implication is straightforward. Pre-Roll is the most natural cross-merchandising candidate in the store. Positioning it near checkout, alongside Edibles displays, or bundled with Vapor Pen promotions is not a speculative retail bet; the attachment data shows consumers are already making these combinations on their own. Formalizing that behavior through placement and promotion is one of the clearest incremental basket-size opportunities available to retailers in both markets.

Pricing

Category Pricing

Pre-Roll's pricing position in both markets tells a consistent story: the format sits well above Flower on a per-gram basis, a reflection of the convenience premium consumers are willing to pay, while remaining far more accessible than Vapor Pens or Concentrates. That middle-ground position is a structural advantage, and in Q1 2026 it held firm.

In the US, Pre-Roll averaged $5.74 EQ Price per gram, sitting comfortably above Flower at $3.80 but well below Vapor Pens ($21.84) and Concentrates ($14.61). The format actually ticked up +0.6% QoQ, one of the few categories to avoid quarter-over-quarter pressure. The harder number is the YoY figure: down 8%, roughly in line with Flower (-8.9%) and Vapor Pens (-8.8%). The whole US inhalable market is in a deflationary cycle, and Pre-Roll is moving with it rather than against it. The category is not losing pricing power relative to its peers; it is declining alongside them in a broadly compressed market.

Canada tells a more concerning version of that story. Pre-Roll averaged CAD 7.90 EQ per gram in Q1 2026, down 1.6% QoQ and 5.4% YoY. That YoY decline is steeper than Vapor Pens (-2.1%) and substantially steeper than Flower (-0.5%), meaning Canadian Pre-Roll is losing ground on price faster than the categories it competes with. Given that Canada is the more mature market, this may reflect the natural price compression of a format that has already achieved mass adoption. When a category stops being aspirational and becomes default, margin pressure tends to follow.

Market Pricing

The state-level data reveals how much pricing geography still matters in the US. New York leads all tracked markets at $11.89 per gram while Michigan sits at just $2.96, a spread that reflects differences in tax structure, market maturity, and competitive intensity rather than differences in product quality. For brands, that range is not just informational; it determines where margin is possible and where volume is the only viable strategy.

On momentum, Oregon was the one bright spot at +5.9% QoQ. Connecticut saw the sharpest pullback at -4% QoQ and the steepest YoY erosion at -23.7%, a pattern shared by New York and New Jersey. All three are newer recreational markets that launched at elevated price points and are now correcting toward competitive parity with more established states. That convergence is not necessarily alarming; it reflects a market working out where prices actually belong. For brands, it also signals genuine room for price-led growth strategies in these markets while consumers are still forming habits. Colorado stands as the lone YoY gainer at +0.7%, modest but notable given the direction of the broader market.

Canada's provincial spread is narrower but the directional pressure is the same. BC leads at CAD 8.33 per gram and Alberta follows at CAD 8.19, with Saskatchewan at the bottom at CAD 7.52. The gap between the highest and lowest province is less than a dollar. That compression reflects a more standardized retail environment and less variation in tax and regulatory burden across provinces.

All four provinces declined QoQ, with BC and Alberta each falling roughly 2.7%. The YoY picture is more uneven: Saskatchewan is down 7.4% and Ontario 6.6%, while the national average sits at -5.4%. The provinces that built the largest Pre-Roll markets earliest are now experiencing the most pronounced price normalization, which is a pattern worth monitoring as US markets continue to mature.

Pricing Over Time

Zoom out 15 months and the trajectory in the US is clear but not alarming. Pre-Roll EQ price fell from $6.23 in January 2025 to $5.77 by March 2026, a decline of about 7%. Vapor Pens dropped from $24.39 to $21.69 over the same window, a steeper absolute and relative fall. Flower also drifted lower. Pre-Roll is compressing at a measured pace that tracks the broader market rather than underperforming it. The category is not in a race to the bottom; it is participating in a broad, industry-wide compression.

Canada's 15-month arc is similar in direction but sharper in slope for Pre-Roll specifically. Prices fell from CAD 8.38 in January 2025 to CAD 7.86 by March 2026, while Vapor Pens moved from CAD 34.65 to CAD 33.70, a much gentler slide. Flower held largely flat. Pre-Roll is the outlier in Canada: the category leading the market in sales share is also experiencing above-average price erosion. For Canadian operators, the volume growth story remains strong, but the margin story is getting harder to tell.

Demographics

Age Group

In the US, Pre-Roll's age profile is notably close to the overall cannabis market, which is itself a meaningful finding. Millennials lead at 43.5% of category sales, consistent with their dominance across most cannabis categories. Generation X over-indexes by 1 pp relative to the total market, the largest positive skew of any cohort, suggesting the format resonates with slightly older, established consumers who may value convenience and consistency over novelty. Generation Z under-indexes by 1.3 pp, a modest gap, but one worth watching given the cohort's long-term purchasing trajectory. Pre-Roll is not losing Gen Z; it simply has not yet over-indexed with them the way some newer formats such as Vapor Pens have.

Canada's age skew is sharper and points to a structural consideration for the category's future. Millennials lead at 46.5%, and Generation X over-indexes by a notable 3.7 pp. The more telling number is Gen Z, which sits 5 pp below its overall market share in Pre-Roll. In a country where Pre-Roll has already achieved category leadership, a consistent underperformance with the youngest legal-age cohort raises a longer-term question about whether the format's dominance is durable as generational buying power shifts. The data does not suggest a crisis, but it does suggest that brands in Canada have work to do to broaden appeal downward in age.

Gender

Pre-Roll consistently over-indexes with women in both markets, a pattern that runs counter to the male-skewed norms of most cannabis categories and has real implications for how the format is positioned and marketed.

In the US, women account for 38.8% of Pre-Roll sales versus 34.4% across all cannabis categories, a +4.4 pp premium. Men still lead in absolute terms at 61.2%, but their share of Pre-Roll spend is meaningfully lower than their 65.6% share of the total market. The format's convenience, approachability, and social consumption context appear to drive broader gender appeal than categories like Concentrates, which skew more heavily male.

Canada mirrors the pattern almost exactly. Women hold 40.8% of Pre-Roll spend against a 36.8% baseline across all categories, a +4 pp lift. The consistency of this finding across two very different regulatory environments and consumer cultures suggests it reflects something genuine about the format's appeal rather than a market-specific anomaly. For brands building creative and retail strategy, Pre-Roll's female over-index is one of the clearest demographic edges the category has.

Conclusion

The Pre-Roll category enters the second half of 2026 with more momentum than at any point in its history, and with more complexity than the headline numbers suggest.

The US and Canada are genuinely different markets now, not just in scale but in character. The US is still in a growth phase, with share gains broadening across states, infused formats pulling the category upmarket, and multipacks converting single-occasion buyers into repeat purchasers. Canada has crossed into a different stage: dominant share, compressed prices, and a format mix that is rotating back toward traditional products. The strategic questions in each market are not the same, and brands that treat North America as one Pre-Roll market will misread both.

The demographic picture offers both reassurance and a caution. Pre-Roll's consistent female over-index across two different regulatory environments points to genuine cross-gender appeal that most cannabis categories have not achieved. The Gen Z gap in Canada is the counterpoint: a category that leads the market but under-performs with its youngest legal-age consumers has a succession question it has not yet answered.

On pricing, the direction is clear and unlikely to reverse. The relevant question for operators is not whether prices will fall further but how fast, and whether product innovation can outpace the compression. In the US, infused formats are currently providing that buffer. In Canada, the buffer is thinner.

For brands, retailers, and investors, the signal in 2026 is consistent with what it has been for several years: Pre-Roll is not a category to watch from the sidelines. The markets that moved earliest are now the most competitive. The markets that are still developing are the ones with the most room to run.

‍